Serum neopterin and soluble CD163 as markers of macrophage activation in paracetamol (acetaminophen)-induced human acute liver injury

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 11-12, 2013, Pages 1395-1404

  Craig, D G ^a   Lee, P ^b   Pryde, E A ^b   Hayes, P C ^b   Simpson, K J ^b  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMINOPHEN; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LIVER FAILURE, ACUTE; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; NEOPTERIN; RECEPTORS, CELL SURFACE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84893707650     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12530     Document Type: Article

References (28)

1. Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology 2005; 42: 1364-72.
2. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32: 734-9.
3. Vaquero J, Polson J, Chung C, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 2003; 125: 755-64.
4. Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with nonparacetamol- induced acute liver failure. Gut 2009; 58: 443-9.
5. Craig DG, Reid TW, Martin KG, Davidson JS, Hayes PC, Simpson KJ. The systemic inflammatory response syndrome and sequential organ failure assessment scores are effective triage markers following paracetamol (acetaminophen) overdose. Aliment Pharmacol Ther 2011; 34: 219-28.
6. Possamai LA, Antoniades CG, Anstee QM, et al. Role of monocytes and macrophages in experimental and human acute liver failure. World J Gastroenterol 2010; 16: 1811-9.
7. Holt MP, Cheng L, Ju C. Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury. J Leukoc Biol 2008; 84: 1410-21.
8. Antoniades CG, Quaglia A, Taams LS, et al. Source and characterization of hepatic macrophages in acetaminopheninduced acute liver failure in humans. Hepatology 2012; 56: 735-46.
9. Hiraoka A, Horiike N, Akbar SM, Michitaka K, Matsuyama T, Onji M. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure. J Gastroenterol 2005; 40: 52-6.
10. Moller HJ, Gronbaek H, Schiodt FV, et al. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol 2007; 47: 671-6.
11. Jaeschke H. Innate immunity and acetaminophen-induced liver injury: why so many controversies? Hepatology 2008; 48: 699-701.
12. Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 2001; 26: 319-29.
13. Sucher R, Schroecksnadel K, Weiss G, Margreiter R, Fuchs D, Brandacher G. Neopterin, a prognostic marker in human malignancies. Cancer Lett 2010; 287: 13-22.
14. Demirbas S, Cakir E, Akgul EO, et al. Elevated serum neopterin levels in acetaminophen-induced liver injury. Environ Toxicol Pharmacol 2011; 31: 165-70.
15. Simpson KJ, Bates CM, Henderson NC, et al. The utilization of liver transplantation in the management of acute liver failure: comparison between acetaminophen and non-acetaminophen etiologies. Liver Transpl 2009; 15: 600-9.
16. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamolinduced acute liver failure: a cohort study. Lancet 2002; 359: 558-63.
17. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-74.
18. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis- Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-10.
19. Yaman H, Cakir E, Ozcan O, et al. Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clin Biochem 2005; 38: 187-90.
20. Wang Z, Dong M, Chu H, et al. Increased serum levels of neopterin and soluble interleukin-2 receptor in intrahepatic cholestasis of pregnancy. Acta Obstet Gynecol Scand 2004; 83: 1067-70.
21. Melichar B, Solichova D, Svobodova I, Urbanek L, Vesely P, Melicharova K. Urinary neopterin in patients with liver tumors. Tumori 2006; 92: 318-22.
22. Antoniades CG, Triantafykkou E, Gadhok R, et al. CD163 is a mechanistic biomarker in acute liver failure reflecting a macrophage activation like syndrome. J Hepatol 2013; 58: S417.
23. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 1995; 133: 43-52.
24. Jalan R, Pollok A, Shah SH, Madhavan K, Simpson KJ. Liver derived proinflammatory cytokines may be important in producing intracranial hypertension in acute liver failure. J Hepatol 2002; 37: 536-8.
25. Berry PA, Antoniades CG, Hussain MJ, et al. Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis. Liver Int 2010; 30: 733-40.
26. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-69.
27. Laskin DL, Sunil VR, Gardner CR, Laskin JD. Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol 2011; 51: 267-88.
28. Antoniades CG, Berry PA, Davies ET, et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology 2006; 44: 34-43.